Evaluating No Evidence of Disease Activity in Patients With Relapsing Multiple Sclerosis: Post Hoc Analysis of the Phase 3 RADIANCE and Open-Label Extension Studies of Ozanimod

Authors
Category Primary study
JournalNeurology
Year 2022
This article has no abstract
Epistemonikos ID: b42e8a2152acfaffdc7e23b4c9e6a5e284b1868f
First added on: Feb 14, 2025